AstraZeneca To Make Seroquel Label Changes

Law360, New York (February 26, 2009, 12:00 AM EST) -- At the request of federal regulators, AstraZeneca Pharmaceuticals LP has agreed to modify the warning label on its blockbuster anti-psychotic medication Seroquel to make information about potential health risks more prominent.

AstraZeneca has specifically agreed to move information about weight gain and changes in blood sugar levels from the “vital signs” section to the “warning” section of Seroquel's label at the FDA's request, according to a report Friday in the Philadelphia Inquirer.

The company revealed the changes to the label of the controversial drug as part...
To view the full article, register now.